Company Overview
- Website
- bridgemedicines.com
- Phone
- (415) 835-9385
- Employees
- 3
- Industry
- Materials/Manufacturing
- SIC Code
-
2834 - Pharmaceutical Preparations
Financials & Stats
Revenue
$3B
Recent News & Media
Deerfield secures more than $600M for its next biotech venture fund
- May 5, 2025
- biopharmadive.com
Crebbp Inhibition Potentiates JAK2 Inhibition in Post-MPN Acute Myeloid Leukemia
- Nov 5, 2024
- sciencedirect.com
Galecto buys leukemia drug from Bridge Medicines, drops bone cancer asset in strategic pivot
- Oct 7, 2024
- fiercebiotech.com
Galecto Completes Strategic Review to Focus on Oncology and
- Oct 7, 2024
- globenewswire.com
Inhibitors of ENL/AF9 YEATS and FLT3 disclosed in Bridge Medicines patent
- Apr 4, 2024
- bioworld.com
Bridge Medicines Enters Exclusive License Agreement with Cornell University for UBR5 Inhibitor Program to Treat Resistant Cancers
- Jul 28, 2021
- prnewswire.com
Companies Similar to Bridge Medicines
Analyze industry trends and opportunities by examining competitors and companies comparable to Bridge Medicines, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 11 | New York, NY | 2018 | |
| 3M | 2 | Alpharetta, GA | ||
| 3M | 3 | Syracuse, NY | ||
| 3M | 17 | Austin, TX | 1996 | |
| 3M | 5 | New York, NY | 2012 |